Hyperinsulinemia Impairs Clathrin-Mediated Endocytosis of the Insulin Receptor and Activation of Endothelial Nitric Oxide Synthase in Brain Endothelial Cells.
brain insulin transport
endosomes
insulin resistance
insulin signaling
internalization
obesity
transcytosis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
received:
07
08
2023
revised:
15
09
2023
accepted:
26
09
2023
medline:
23
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Adequate perfusion of cerebral tissues, which is necessary for the preservation of optimal brain health, depends on insulin signaling within brain endothelial cells. Proper insulin signaling relies on the regulated internalization of insulin bound to the insulin receptor, a process which is disrupted by hyperinsulinemia via an unknown mechanism. Thus, the goal of this study was to characterize the impact of hyperinsulinemia on the regulation of molecular targets involved in cerebral blood flow and insulin receptor internalization into brain endothelial cells. The phosphorylation of molecular targets associated with cerebral blood flow and insulin receptor internalization was assessed in hyperinsulinemic brain endothelial cells. Insulin receptor uptake into cells was also examined in the setting of endocytosis blockade. Our data demonstrate that hyperinsulinemia impairs the activation of endothelial nitric oxide synthase. These data correspond with an impairment in clathrin-mediated endocytosis of the insulin receptor and dysregulated phosphorylation of key internalization effectors. We conclude that hyperinsulinemia alters the phosphorylation of molecular targets involved in clathrin-mediated endocytosis, disrupts signaling through the insulin receptor, and hinders the capacity for blood flow regulation by brain endothelial cells.
Identifiants
pubmed: 37834116
pii: ijms241914670
doi: 10.3390/ijms241914670
pmc: PMC10572607
pii:
doi:
Substances chimiques
Receptor, Insulin
EC 2.7.10.1
Nitric Oxide Synthase Type III
EC 1.14.13.39
Insulin
0
Clathrin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NINDS NIH HHS
ID : 1R01NS099595
Pays : United States
Organisme : BLRD VA
ID : I01 BX005666
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001451
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20GM109040
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001451, UL1 TR001450
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS099595
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109040
Pays : United States
Organisme : Alzheimer's Association
ID : AARGD-23-970621
Pays : United States
Références
Neurobiol Dis. 2019 Dec;132:104580
pubmed: 31454547
Mol Cell Biol. 1998 Jul;18(7):3862-70
pubmed: 9632770
Alzheimers Dement. 2020 Dec;16(12):1714-1733
pubmed: 33030307
Nat Commun. 2013;4:1673
pubmed: 23575677
Clin Cornerstone. 1999;2(3):17-31
pubmed: 10696282
Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E134-44
pubmed: 20959538
Exp Mol Med. 2020 Jun;52(6):911-920
pubmed: 32576931
J Cereb Blood Flow Metab. 2017 Aug;37(8):2848-2856
pubmed: 27789785
J Physiol. 2018 Oct;596(19):4753-4765
pubmed: 30044494
Endocr Rev. 2007 Aug;28(5):463-91
pubmed: 17525361
Mol Pharm. 2014 Aug 4;11(8):2887-95
pubmed: 24949999
Biochim Biophys Acta. 2015 Oct;1848(10 Pt A):2101-10
pubmed: 26055893
Pharm Res. 2014 Jul;31(7):1855-66
pubmed: 24558007
PLoS One. 2009 Jun 19;4(6):e5985
pubmed: 19543529
J Vis Exp. 2012 Jun 08;(64):e3884
pubmed: 22710268
PLoS Med. 2020 Jun 8;17(6):e1003138
pubmed: 32511229
Diabetes Metab J. 2022 Jan;46(1):15-37
pubmed: 34965646
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33879610
Nat Commun. 2019 Apr 1;10(1):1473
pubmed: 30931927
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1943-50
pubmed: 22628433
Pharmacol Rev. 2009 Mar;61(1):62-97
pubmed: 19293146
Int J Mol Sci. 2019 Oct 10;20(20):
pubmed: 31658625
Brain Imaging Behav. 2017 Oct;11(5):1248-1257
pubmed: 27714551
J Endocr Soc. 2019 Jul 24;3(9):1727-1747
pubmed: 31528832
J Clin Invest. 2012 Apr;122(4):1316-38
pubmed: 22476197
Histol Histopathol. 2010 Jan;25(1):99-112
pubmed: 19924646
Front Neurosci. 2019 Jan 11;12:1019
pubmed: 30686985
Diabetologia. 2017 Aug;60(8):1512-1521
pubmed: 28601906
J Cereb Blood Flow Metab. 2017 Jun;37(6):2249-2261
pubmed: 27488909
Trends Endocrinol Metab. 2015 Jun;26(6):297-304
pubmed: 25735473
Science. 1985 Mar 29;227(4694):1583-6
pubmed: 3883490
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209489
Diabetes. 2014 Dec;63(12):3992-7
pubmed: 25414013
Circulation. 2017 Aug 22;136(8):719-728
pubmed: 28588075
Fluids Barriers CNS. 2020 Nov 18;17(1):69
pubmed: 33208141
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E531-E542
pubmed: 29584446
BMJ. 2021 Mar 16;372:n365
pubmed: 33727242
Cell. 2002 May 17;109(4):523-35
pubmed: 12086608
Mol Biol Cell. 2015 Feb 15;26(4):740-50
pubmed: 25540431
Cell Logist. 2012 Oct 1;2(4):203-208
pubmed: 23538558
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927
Diab Vasc Dis Res. 2022 Jul-Aug;19(4):14791641221118626
pubmed: 35975361
Cell Mol Neurobiol. 2016 Mar;36(2):281-8
pubmed: 27095366